Dexcom | DXCM - 债务利息支出



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 35.19B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


债务利息支出 更改 日
Abbott USD 299M 231M 2026-06
Align Technology USD 6.93M 9.11M 2026-03
AtriCure USD 1.21M 159K 2026-03
Baxter International USD 78M 20M 2026-03
Becton, Dickinson and Co. USD 132M 17M 2026-06
Boston Scientific USD 96M 6M 2026-06
Cooper Companies USD 20.9M 1.5M 2026-03
Dexcom USD 3.1M 1.1M 2026-03
Edwards Lifesciences USD 30M 5.9M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Inogen 1.03M 384K 2025-03
Insulet USD 11M 3.7M 2026-06
Integra LifeSciences USD 22.99M 529K 2026-06
J&J USD 43M 25M 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 12.12M 5.59M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Solventum Corp USD 14.24B 146M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 27.95M 2.24M 2026-06
West Pharmaceutical Services USD 1.9M 1.7M 2026-03
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06